MedTrace Logo

Cyanotic Heart Disease and Thrombosis

NCT02716402 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-29

No results posted yet for this study

Summary

The purpose of the study is to examine previously examined patients with cyanotic congenital heart disease to assess how many of the patients have obtained additional blood clots since they were examined 8 years ago.

Conditions

Interventions

RADIATION

Cerebral MRI and V/Q SPECT/CT

Cerebral MRI and V/Q SPECT/CT

Sponsors & Collaborators

  • Annette Schophuus Jensen

    lead OTHER

Principal Investigators

  • Annette S Jensen, MD, PhD · Rigshospitalet, Denmark

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-05-31
Completion
2017-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02716402 on ClinicalTrials.gov